
Consultant, Ground Zero Pharmaceuticals, Inc.
Member of the Healthcare Council
Michael R. Hamrell, PhD, is the President of MORIAH Consultants and a Strategic Regulatory Affairs Consultant for Ground Zero Pharmaceuticals in Irvine, CA. Dr. Hamrell has extensive experience in regulatory affairs, clinical research and drug development at FDA, NIH and industry, emphasizing biotechnology and high-risk diseases. He has experience in the use of computers in document preparation and submission, IND/NDA submissions, adverse experience reporting, clinical regulatory compliance and strategic planning. Dr. Hamrell has published numerous papers in pharmacology, regulatory affairs, product development, clinical research, computers and information systems. He served as a founding Editorial Board member for Applied Clinical Trials and RA FOCUS, as a member of the Editorial Board of the DIA Journal and serves on the Editorial Board of Applied Clinical Trials, Clinical Trials Advisor, the DIA Forum and is the past Editor-in-Chief of the Drug Information Journal. (This is me - Update Profile)
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
Michael Hamrell has not published any GLG News Analyses.